PAR listed as a SELL in today's Herald Sun:
"The drug developer to treat osteoarthritis has seen its stock bounce back strongly but with concerns, such as the quality of its phase 2b trial, positions can be trimmed"
What a load of BS
Ann: NEW FINANCIAL YEAR UPDATE, page-100
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $99.69M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 28.5¢ | 28.0¢ | $18.32K | 65.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32325 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 12374 | 3 |
View Market Depth
| Last trade - 11.07am 10/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |